3SBio Inc. (NASDAQ: SSRX) today announced that it has submitted its application for a Phase I clinical trial for NuPIAO ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE